 YARDLEY, Pa., July 30, 2020 GLOBE NEWSWIRE -- Optinose NASDAQ:OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced the Company will report financial results for the second quarter 2020 and corporate updates, before market open on Tuesday, August 4, 2020. Company to Host Conference Call Members of the Companys leadership team will host a conference call to discuss financial results and corporate updates, including its launch of XHANCE. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, August 4, 2020.To participate on the conference call, please dial 866 916-4761 from the U.S. or 1 409 216-6496 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until Tuesday, August 11, 2020 by dialing 855 859-2056 from the U.S. or 1 404 537-3406 from outside the U.S. and entering conference ID 2298719. A simultaneous webcast of the call and presentation can be accessed by visiting the Investors section of Optinoses website at In addition, a replay of the webcast will be available on the Company website for 60 days following the event.About Optinose Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat ENT and allergy specialists. To learn more, please visit or follow us on Twitter and LinkedIn.Optinose Investor Contact Jonathan Neely 267.521.0531 